Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.
An announcement from Recursion Pharmaceuticals ( ($RXRX) ) is now available. On October 29, 2025, Recursion Pharmaceuticals announced that Roche ...
JDK 25 brings powerful new features to Java and JVM developers. Here are seven new or updated features that could convince ...
Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and report its third quarter 2025 ...
Microsoft introduced a new video series that teaches Java developers how to build generative AI applications using modern ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks Jim Cramer was focused on recently. A caller asked if the ...